Outlook Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	23.39	17.4	14.48	12.54	8.02	1.72	3.19	2.57	9.28	2.56
Cash & Cash Equivalents	23.39	17.4	14.48	12.54	8.02	1.72	3.19	2.57	9.28	2.56
Cash Growth	34.46%	20.17%	15.49%	56.40%	366.73%	-46.09%	24.05%	-72.34%	262.57%	-
Receivables	0	0	0	0	0	0	0	0	0.02	0
Other Current Assets	7.59	10.12	7.03	5.41	5.49	1.59	0.72	3.11	5.86	0.59
Total Current Assets	30.98	27.52	21.51	17.94	13.5	3.3	3.9	5.68	15.16	3.15
Property, Plant & Equipment	0.03	0.07	0.28	0.49	3.18	18.49	16.09	18.66	17.76	8.01
Long-Term Investments	0.79	0.8	0.85	0	0	0	0	0	0	0
Other Long-Term Assets	0.5	0.13	0.17	1.29	0.46	0.49	0.74	1.07	2.08	0.45
Total Long-Term Assets	1.32	1.01	1.3	1.79	3.63	18.98	16.83	19.73	19.84	8.46
Total Assets	32.3	28.53	22.81	19.73	17.13	22.28	20.73	25.41	35.01	11.6
Accounts Payable	6.57	3.49	2.2	2.39	2.28	3.61	10.95	5.07	11.56	3.1
Deferred Revenue	0	0	0	0	0	4.5	7.55	6.37	8.35	7.81
Current Debt	35.56	10.95	0.97	0.27	7.92	13.77	0.39	1.56	15.82	11.48
Other Current Liabilities	4.6	5.28	3.58	13.23	10.09	10.17	9.84	7.44	1.31	-2.19
Total Current Liabilities	46.73	19.73	6.75	15.89	20.29	32.04	28.74	20.44	37.04	20.21
Long-Term Debt	0	0	10.93	0.95	3.42	3.55	13.41	2.55	4.14	3.69
Other Long-Term Liabilities	0.01	0.06	0.52	0.07	4.2	7.5	9.31	7.59	21.38	8.15
Total Long-Term Liabilities	0.01	0.06	11.45	1.02	7.61	11.05	22.72	10.14	25.52	11.84
Total Liabilities	46.74	19.79	18.2	16.91	27.9	43.09	51.46	30.58	62.56	32.05
Total Debt	35.56	10.96	11.9	1.21	11.33	17.32	13.8	4.12	19.96	15.17
Debt Growth	224.47%	-7.93%	880.24%	-89.29%	-34.56%	25.45%	235.21%	-79.37%	31.60%	-
Retained Earnings	-467.92	-408.94	-342.88	-289.72	-254.48	-216.31	-186.22	-147.37	-94.06	-45.15
Shareholders' Equity	-14.44	8.74	4.61	2.83	-16.13	-25.54	-33.65	-5.17	-54.22	-45.15
Net Cash / Debt	-12.16	6.44	2.57	11.32	-3.32	-15.6	-10.62	-1.55	-10.68	-12.61
Net Cash / Debt Growth	-	150.06%	-77.26%	-	-	-	-	-	-	-
Net Cash Per Share	-0.97	0.61	0.34	3.12	-3.65	-63.26	-70.67	-14.41	-175.15	-237.05
Working Capital	-15.75	7.79	14.76	2.06	-6.79	-28.74	-24.83	-14.76	-21.88	-17.06
Book Value Per Share	-1.15	0.82	0.60	0.78	-17.73	-103.58	-224.13	-48.08	-889.42	-848.94

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).